[PERSON]
Ulcerative colitis
Featured in 3 tracked stories · first seen
Situations
Guselkumab reimbursement approval in Italy
2 clusters · 13 sources · last updated
Latest: Italy approves reimbursement for Guselkumab for bowel diseases
Italy has approved reimbursement for the Johnson & Johnson drug guselkumab (Tremfya) to treat two specific inflammatory bowel diseases: moderate to severe active ulcerative colitis and moderate to severe active Crohn’s d
Also covered in
-
Health indicators: Walking speed and abdominal symptoms
[HEALTH] · 2 sources ·
-
Vietnam health bulletins warn on detox fads and highlight blueberry benefits
[HEALTH] · 2 sources ·